Research Paper Volume 16, Issue 9 pp 7774—7798
The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma
Figure 1. The workflow diagram delineates the methodologies and resources employed in this investigation.